SCHEMBL15910954

SCHEMBL15910954

Cn1cc(-c2cc(N)c3cnn(C)c3c2)cn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AURKA O14965 1/20 0.50
▸ TTK P33981 1/20 0.50
▸ AURKB Q96GD4 1/20 0.50
▸ INCENP Q9NQS7 1/20 0.50
▸ MAP4K1 Q92918 2/20 0.42
▸ AXL P30530 2/20 0.40
▸ PIK3CD O00329 1/20 0.40
▸ PIK3CA P42336 1/20 0.40
▸ PIK3CB P42338 1/20 0.40
▸ PI4KA P42356 1/20 0.40
▸ PIK3CG P48736 1/20 0.40
▸ PI4KB Q9UBF8 1/20 0.40
▸ SYK P43405 1/20 0.40
▸ SMARCA2 P51531 1/20 0.39
▸ SMARCA4 P51532 1/20 0.39
▸ METAP2 P50579 1/20 0.38
▸ KDM1A O60341 1/20 0.38
▸ MET P08581 2/20 0.38
▸ MKNK1 Q9BUB5 1/20 0.38
▸ MKNK2 Q9HBH9 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15910918 0.78 ERN1 (0.56) AURKATTKAURKBINCENPSYK
SCHEMBL27228033 0.74 ADORA2A (0.39) PI4KAPI4KB
SCHEMBL30861129 0.74 ADORA2A (0.39) PI4KAPI4KB
SCHEMBL17476796 0.73 AURKB (0.55) AURKATTKAURKBINCENPAXL
SCHEMBL459070 0.73 IDO1 (0.42) PI4KAPI4KB
SCHEMBL30860950 0.73 PI4KA (0.37) PI4KAPI4KB
SCHEMBL4718490 0.73 PI4KA (0.37) PI4KAPI4KB
SCHEMBL23081414 0.72 AURKA (0.51) AURKATTKAURKBINCENPMAP4K1
SCHEMBL30210556 0.71 MAPT (0.48) AURKATTKAURKBINCENPMAP4K1
SCHEMBL21603501 0.70 ALDH1A1 (0.54) AURKATTKAURKBINCENPMAP4K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9145414-B2 1,2,4-triazine-6-carboxamide derivative TAIHO PHARMACEUTICAL CO., LTD. (JP) 2015-09-29 — — US disclosed
US-20140343038-A1 1,2,4-TRIAZINE-6-CARBOXAMIDE DERIVATIVE TAIHO PHARMACEUTICAL CO., LTD. (JP) 2014-11-20 — — US disclosed
EP-2762476-A1 1,2,4-TRIAZINE-6-CARBOXAMIDE DERIVATIVE Taiho Pharmaceutical Co., Ltd. (JP) 2014-08-06 — — EP disclosed
US-7238766-B2 Synthesis of elastomeric carborane-siloxanes by hydrosilation reactions THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2007-07-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140343038-A1 1,2,4-TRIAZINE-6-CARBOXAMIDE DERIVATIVE SYK, BTK, JAK2 AURKA 945/4885TTK 3893/4885AURKB 1375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback